Lessons from the National institutes of health innovation corps program: defining barriers to developing and commercializing novel solutions for persons with opioid use disorder
It is critical for innovators to have early interactions with the full range of OUD stakeholders to identify and quantify true unmet needs and to properly position development programs for commercial success. The NIH I-Corps program provides a framework to educate researchers to support their product design and development plans to increase the probability of a commercially successful outcome to address the ongoing opioid epidemic.
Authors
- V.I. Prikhodko
- Michael Greenberg (ORCID: https://orcid.org/0000-0002-2576-9794)
- M. Jo Hite
- Matthew Heshmatipour (ORCID: https://orcid.org/0000-0002-2831-5106)
- Ariana M. Nelson (ORCID: https://orcid.org/0000-0003-1575-1635)
- Eboo Versi (ORCID: https://orcid.org/0000-0001-9366-7370)
- David Reeser
- Desislava Z. Hite
- Tyler M. Duvernay
- Bina Julian
Institutions
- Rutgers, The State University of New Jersey (US)
- University of California, Irvine (US)
Publication Details
- Journal
- Addiction Science & Clinical Practice
- Published
- 2025-03-12
- DOI
- https://doi.org/10.1186/s13722-025-00554-1
- Citations
- 1
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.88
Funders
- National Institute on Drug Abuse